Page Menu

Central Nervous System Clinical Trials

Central nervous system clinical trials are an important part of cancer treatment for two main reasons. First, they allow certain patients with various types of brain and spinal cancer to be among the first to benefit from promising new treatment approaches. And second, as the best and most reliable way to determine the effectiveness of a new treatment, clinical trials provide the evidence physicians need to improve the care of all current and future cancer patients.

Moffitt Cancer Center is highly respected for the breakthroughs we’ve achieved through our research efforts and clinical trials, which have resulted in numerous advances in the prevention, diagnosis and treatment of cancer. Our work is recognized by the National Cancer Institute, which has awarded us the designation of Comprehensive Cancer Center. This honor is bestowed on only a select few institutions that have made a significant and proven impact on cancer care by translating laboratory discoveries into better outcomes and higher-quality lives for patients.

Currently, the researchers at Moffitt are working on developing promising new strategies for treating primary and metastatic brain and spinal tumors. Some of the treatments available in our central nervous system clinical trials include:

  • Vaccines
  • Immunotherapy
  • Biological therapies Intrathecal chemotherapy with standard drugs, biological agents and targeted molecular agents
  • Other novel chemotherapy agents and combinations that cross the natural barrier that protects the brain

We also offer clinical trials for metastatic brain and spinal tumors, including those associated with melanoma, lung cancer and breast cancer.

At Moffitt, we encourage our patients to consider enrolling in clinical trials as early as possible, and preferably at the time of diagnosis. A common misconception about clinical trials is that they are experimental. This is not the case. A participant in a clinical trial will receive either the standard of care, which is the best treatment currently available for the specific type of cancer, or a promising new treatment. Until a time when the standard of care for central nervous system tumors is curative, clinical trials will play a vital role in the treatment of brain and spinal cancers.

To learn more about the central nervous system clinical trials available at Moffitt Cancer Center, call call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. We do not require referrals.

 

calledFromCancerPage=True - substr=
testProtocol=

Open Clinical Trials:

Showing of 50

CLINICAL TRIAL 18752

ACTION Trial- Adoptive Cellular Therapy following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I)

Disease Site: Brain and Nervous System, Gliomas

View Trial Details

CLINICAL TRIAL 19327

A Phase 2 Trial of Pembrolizumab Plus Bevacizumab in Patients with Metastatic Melanoma or Non-small Cell Lung Cancer with Untreated Brain Metastases

Disease Site: Non small cell lung cancer, Brain and Nervous System, Lung, Melanoma, skin, Gliomas

View Trial Details

CLINICAL TRIAL 19970

A Pilot Trial of Intratumorally-Administered Topotecan using Convection-Enhanced Delivery (CED) in Patients with Suspected Recurrent/Progressive WHO Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy (IND 117,240)

Disease Site: Brain and Nervous System

View Trial Details

CLINICAL TRIAL 20487

Phase I/II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease

Disease Site: Brain and Nervous System, Breast, Leptomeningeal (LMD)

View Trial Details

CLINICAL TRIAL 20899

Phase I/II Study of Stereotactic Radiation and Abemaciclib in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases

Disease Site: Brain and Nervous System, Breast

View Trial Details

CLINICAL TRIAL 20956

A Two-Part, Phase 1a/B, Open-Label, Multicenter Trial Evaluating Pharmacokinetics, Safety and Efficacy Of PF-07284890 (ARRY-461) In Participants With BRAF V600-Mutant Solid Tumors With And Without Brain Involvement

Disease Site: Any Site, Brain and Nervous System, Larynx, Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Other Skin, Brain metastasis, Gliomas

View Trial Details

CLINICAL TRIAL 20964

A Phase 2 Basket Study of Tucatinib in Combination with Trastuzumab in Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations

Disease Site: Brain and Nervous System, Breast, Ill-Defined Sites, Lung, Other Digestive Organ, Urinary Bladder, Brain metastasis, Leptomeningeal (LMD)

View Trial Details

CLINICAL TRIAL 21022

A Phase 1b/2, Master Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 (pINN sotorasib) in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation

Disease Site: Any Site, Brain and Nervous System, Lung, Pancreas, Rectum, Brain metastasis, Leptomeningeal (LMD)

View Trial Details

CLINICAL TRIAL 21039

A Pivotal Randomized, Open-Label Study Of OPTUNE(R)(TTFIELDS, 200KHZ) Concomitant With Radiation Therapy And Temozolomide For The Treatment Of Newly Diagnosed Glioblastoma

Disease Site: Brain and Nervous System, Gliomas

View Trial Details

CLINICAL TRIAL 21193

Pre-operative Hypofractionated Stereotactic Radiosurgery for Resectable Brain Metastases

Disease Site: Brain and Nervous System, Brain metastasis

View Trial Details

CLINICAL TRIAL 19731

Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator Intervention for Neuro-Oncology Couples

Disease Site: Brain and Nervous System, Brain metastasis, Gliomas, Leptomeningeal (LMD), Meningiomas

View Trial Details

CLINICAL TRIAL 21737

A Pilot Study of Advanced Multi-parametric MRI to Evaluate De Novo Glioblastoma Tumors Prior to Surgical Resection

Disease Site: Brain and Nervous System, Gliomas

View Trial Details